Dr. Wise Young has never met the hundreds of thousands of people he has helped in the past 10 years, and most of them have never heard of Wise Young. If they did meet him, however, they'd want to shake his hand--and the remarkable thing about that would be the simple fact that so many of them could. All the people Young has helped were victims of spinal injuries, and they owe much of the mobility they have today to his landmark work.

　　Young, 51, head of the W.M. Keck Center for Collaborative Neuroscience at Rutgers University in New Brunswick, N.J., was born on New Year's Day at the precise midpoint of the 20th century. Back then, the thinking about spinal-cord injury was straightforward: When a cord is damaged, it's damaged. There's nothing that can be done after an injury to restore the function that was so suddenly lost. As a medical student at Stanford University and a neurosurgeon at New York University Medical Center, Young never had much reason to question that received wisdom, but in 1980 he began to have his doubts. Spinal cords, he knew, experience progressive damage after they're injured, including swelling and inflammation, which may worsen the condition of the already damaged tissue. If that secondary insult could be relieved with drugs, might some function be preserved

　　Young spent a decade looking into the question, and in 1990 he co-led a landmark study showing that when high doses of a steroid known as methylprednisolone are administered within eight hours of an injury, about 20% of function can be saved. Twenty percent is hardly everything, but it can often be the difference between breathing unassisted or relying on a respirator, walking or spending one's life in a wheelchair. "This discovery led to a revolution in neuroprotective therapy," Young says.

　　A global revolution, actually. More than 50,000 people around the world suffer spinal injuries each year, and these days, methylprednisolone is the standard treatment in the U.S. and many other countries. But Young is still not satisfied. The drug is an elixir for people who are newly injured, but the relief it offers is only partial, and many spinal-injury victims were hurt before it became available. Young's dream is to help those people too--to restore function already lost--and to that end he is studying drugs and growth factors that could improve conduction in damaged nerves or even prod the development of new ones. To ensure that all the neural researchers around the world pull together, he has created the International Neurotrauma Society, founded the Journal of Neural Trauma and established a website (carecure.rutgers.edu) that receives thousands of hits each day.

　　"The cure for spinal injury is going to be a combination of therapies," Young says. "It's the most collaborative field I know." Perhaps. But increasingly it seems that if the collaborators had a field general, his name would be Wise Young.

　　1.By “the remarkable thing about that would be the simple fact that so many of them could”(Line three, Paragraph 1), the author means_______________.
　　[A] The remarkable thing is actually the simple fact.
　　[B] Many people could do the remarkable things.
　　[C] When meeting him, many people could do the simple but remarkable thing.
　　[D] The remarkable thing lies in the simple fact that so many people could shake hands with him.

　　2.How did people think of the spinal-cord injury at the middle of 20th century
　　[A] pessimistic
　　[B] optimistic
　　[C] confused
　　[D] carefree

　　3.By saying “Twenty percent is hardly everything”(Line 3, Paragraph 3), the author is talking about_____________.
　　[A] the drug
　　[B] the function of the injured body
　　[C] the function of the drug
　　[D] the injury

　　4.Why was Young unsatisfied with his achievement
　　[A] The drug cannot help the people who had spinal injury in the past.
　　[B] His treatment is standard.
　　[C] The drug only offers help to a small number of people.
　　[D] The drug only treats some parts of the injury.

　　5.To which of the following statements is the author likely to agree
　　[A] Wise Young does not meet many people.
　　[B] When Young was young, he did not have much reason to ask questions.
　　[C] If there needs a head of the spinal-injured field, Young might be the right person.
　　[D] Young’s dream is only to help the persons who were injured at early times.

　　答案：D A B A C

　　篇章剖析

　　本文采用先总括说明，再具体阐述的方法，介绍了杨咏威在治疗脊柱损伤这一领域的贡献。第一段概括了杨咏威对很多遭受脊柱损伤人的帮助；第二段介绍杨咏威如何是对这一领域产生兴趣的；接着第三段描述了杨已经取得的研究成果；从第四段中，我们知道杨对已有的成果并不满足，呼吁这一领域的研究工作者共同努力，进一步探讨这个问题；第五段总括全文，说明杨是这个领域的带头人。

　　词汇注释

　　spinal: [spaInl] adj. 脊柱的，有关脊柱的

　　straightforward [streit5fC:wEd] adj. 坦率的, 易懂的, 直接了当的

　　swelling [5sweliN]n. 肿胀，肿大

　　inflammation [7inflE5meiFEn] n. [医]炎症, 发炎

　　preserve [pri5zE:v] vt.保护, 保持, 保存

　　steroid [5stiErCid] n.[生化]类固醇

　　methylprednisolone [9meWIlpred`nIsElEJn]n. [药]甲强龙,甲基强的松龙, ,6-甲氢化泼尼松

　　administer [Ed5mInIstE(r)] v. 服用，给予作为治疗或药物使用

　　neuroscience [7njuErEu5saiEns] n.神经系统科学( 指神经病学、 神经化学等)

　　respirator [5respEreitE] n.呼吸器

　　elixir [I5lIksE(r)] n. 仙丹妙药, 长生不老药 (= elixir of life)

　　prod [prRd] vt., vi.刺，戳, 督促；推动

　　trauma [5trC:mE] n.[医] 外伤, 损伤

　　collaborative [kE`lAbEreItIv] adj.合作的, 协作的, 协力完成的

　　Rutger University 路特格斯大学

　　W.M. Keck Center 凯克神经科学研究中心

　　New Brunswick 新布伦瑞克市 （美国大西洋沿岸一城市）

　　难句突破

　　1. Young spent a decade looking into the question, and in 1990 he co-led a landmark study showing that when high doses of a steroid known as methylprednisolone are administered within eight hours of an injury, about 20% of function can be saved.(Line 1-3,Paragraph 3)

　　主体句式：Young spent a deacade...and he co-led a study

　　结构分析：这是个复杂句，Young spent a decade looking into the question, and in 1990 he co-led a landmark study是两个并列句，showing引导的句子是现在分词, 修饰study，showing引导的宾语从句又是个复合句，“when high…., about 20% of …当大剂量的…，20％的功能会恢复”。Known as methylprednisolone是过去分词短语，作steroid的后置定语。

　　句子译文：杨咏威花了10年时间钻研这个问题。1990年，他与同仁一起发起了一次具有里程碑意义的调查研究，发现在脊椎受伤8小时内给予高剂量的甲基类固醇，即人们所知的甲强龙，就能够保全伤者20%左右的神经功能，

　　2. Young's dream is to help tho